These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8673754)

  • 1. Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure.
    de Vries RJ; Dunselman PH; Chin Kon Sung UG; van Veldhuisen DJ; Corbeij HM; van Gilst WH; Lie KI
    Heart; 1996 Feb; 75(2):159-64. PubMed ID: 8673754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of calcium antagonists in the management of congestive heart failure: initial experience with lacidipine.
    de Vries RJ; Dunselman PH
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S33-9. PubMed ID: 8852543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy.
    Benatar D; Hall V; Reddy S; Gheorghiade M
    Am J Ther; 1998 Jan; 5(1):25-32. PubMed ID: 10099034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
    Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
    Szabó BM; van Veldhuisen DJ; van der Burgh PH; Kruik J; Girbes AR; Lie KI
    J Card Fail; 1996 Sep; 2(3):185-92. PubMed ID: 8891856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects on peak oxygen consumption, quality of life, and neurohormones of felodipine and enalapril in patients with congestive heart failure.
    de Vries RJ; Queré M; Lok DJ; Sijbring P; Bucx JJ; van Veldhuisen DJ; Dunselman PH
    Am J Cardiol; 1995 Dec; 76(17):1253-8. PubMed ID: 7503006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
    van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI
    J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation.
    Van Den Berg MP; Crijns HJ; Van Veldhuisen DJ; Griep N; De Kam PJ; Lie KI
    J Card Fail; 1995 Dec; 1(5):355-63. PubMed ID: 12836710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial.
    Franciosa JA; Jordan RA; Wilen MM; Leddy CL
    Circulation; 1984 Jul; 70(1):63-8. PubMed ID: 6373050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines.
    de Vries RJ; van Veldhuisen DJ; Dunselman PH
    Am Heart J; 2000 Feb; 139(2 Pt 1):185-94. PubMed ID: 10650289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.
    Littler WA; Sheridan DJ
    Br Heart J; 1995 May; 73(5):428-33. PubMed ID: 7786657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure.
    Kato M; Kinugawa T; Omodani H; Osaki S; Ahmmed GU; Ogino K; Hisatome I; Miyakoda H; Thames MD
    J Card Fail; 1996 Jun; 2(2):103-10. PubMed ID: 8798111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
    Brouwer J; van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Boomsma F; Haaksma J; Lie KI
    J Am Coll Cardiol; 1995 Oct; 26(4):983-90. PubMed ID: 7560628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
    Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA
    Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
    Houghton AR; Harrison M; Cowley AJ
    Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.
    van den Broek SA; de Graeff PA; van Veldhuisen DJ; van Gilst WH; Hillege H; Wesseling H; Lie KI
    J Card Fail; 1997 Sep; 3(3):165-71. PubMed ID: 9330124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure.
    Guazzi M; Palermo P; Pontone G; Susini F; Agostoni P
    Am J Cardiol; 1999 Nov; 84(9):1038-43. PubMed ID: 10569660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.